{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:18Z","timestamp":1790878218523,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.urolonc.2020.04.022","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T17:22:22Z","timestamp":1591118542000},"page":"738.e23-738.e35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation"],"prefix":"10.1016","volume":"38","author":[{"given":"Carina","family":"Bernardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9u","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresina","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edtor","family":"F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Afreixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Brindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Helguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.04.022_bib0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0002","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1017\/S0031182009990552","article-title":"A wake up call for urinary schistosomiasis: reconciling research effort with public health importance","volume":"136","author":"Rollinson","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","author":"Van Der Werf","year":"2003","journal-title":"Acta Trop"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0004","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, IARC Monogr Eval Carcinog Risks Hum. 1994;61:1\u2013241."},{"key":"10.1016\/j.urolonc.2020.04.022_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrurol.2013.53","article-title":"Role of oestrogen receptors in bladder cancer development","volume":"10","author":"Hsu","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0006","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2015.01.018","article-title":"Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer","volume":"359","author":"Gouveia","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0007","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijpara.2009.02.016","article-title":"Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells","volume":"39","author":"Botelho","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng.1065","article-title":"Whole-genome sequence of Schistosoma haematobium","volume":"44","author":"Young","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0009","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1200\/JCO.2005.10.036","article-title":"Estrogen-receptor biology: continuing progress and therapeutic implications","volume":"23","author":"Osborne","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0010","doi-asserted-by":"crossref","unstructured":"Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Treuter E, et al. Estrogen receptors\u202f: how do they signal and what are their targets2007:905\u201331. https:\/\/doi.org\/10.1152\/physrev.00026.2006.","DOI":"10.1152\/physrev.00026.2006"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0011","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-12-0389","article-title":"A bi-faceted role of estrogen receptor \u03b2 in breast cancer","volume":"20","author":"Leygue","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0012","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: Prognostic and therapeutic implications","author":"Yersal","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0013","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrurol.2014.129","article-title":"Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer","volume":"11","author":"Choi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0014","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0015","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","article-title":"A molecular taxonomy for urothelial carcinoma","volume":"18","author":"Sj\u00f6dahl","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0016","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0017","article-title":"Current clinical trials in non\u2013muscle invasive bladder cancer","author":"Siddiqui","year":"2017","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0018","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7196\/SAMJ.8564","article-title":"Comparison of findings using ultrasonography and cystoscopy in urogenital schistosomiasis in a public health centre in rural angola","volume":"105","author":"Santos","year":"2015","journal-title":"South African Med J"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0019","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0020","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0021","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/cncr.21945","article-title":"Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue","volume":"106","author":"Shen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0022","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0023","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.11049","article-title":"Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification","volume":"105","author":"Santos","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0024","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1007\/s13277-013-1604-3","article-title":"Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer","volume":"35","author":"Pinto-Leite","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/jcp.21932","article-title":"Expression of estrogen receptor \u03b2 increases integrin \u03b11 and integrin \u03b21 levels and enhances adhesion of breast cancer cells","volume":"222","author":"Lindberg","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0026","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0308319100","article-title":"Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D","volume":"101","author":"Str\u00f6m","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0027","series-title":"Statistical Power Analysis for the Behavioral Scie","author":"Cohen","year":"1988"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0028","doi-asserted-by":"crossref","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","article-title":"The Human Urine Metabolome","volume":"8","author":"Bouatra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0029","doi-asserted-by":"crossref","first-page":"15059","DOI":"10.1074\/jbc.M009870200","article-title":"Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism","volume":"276","author":"Gangloff","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1107\/S2052520616003954","article-title":"The Cambridge structural database","volume":"72","author":"Groom","year":"2016","journal-title":"Acta Crystallogr Sect B Struct Sci Cryst Eng Mater"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0031","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0032","doi-asserted-by":"crossref","first-page":"o2641","DOI":"10.1107\/S1600536806019726","article-title":"(+)-3,12-Dioxo-5\u03b2-cholanic acid: hydrogen bonding in a diketo bile-acid derivative","volume":"62","author":"Kikolski","year":"2006","journal-title":"Acta Crystallogr Sect E Struct Reports Online"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0033","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.steroids.2008.06.006","article-title":"Syntheses and structural study of bile acid amidoalcohols","volume":"73","author":"Valkonen","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0034","doi-asserted-by":"crossref","first-page":"o742","DOI":"10.1107\/S1600536804007640","article-title":"Adeninium perchlorate adenine dihydrate","volume":"60","author":"Zele\u0148\u00e1k","year":"2004","journal-title":"Acta Crystallogr Sect E Struct Reports Online"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0035","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1158\/1078-0432.CCR-04-0191","article-title":"Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen","volume":"10","author":"Murphy","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0036","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1205420","article-title":"Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera","volume":"21","author":"Chen","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0037","doi-asserted-by":"crossref","first-page":"34753","DOI":"10.1038\/srep34753","article-title":"Antiestrogen resistant cell lines expressing estrogen receptor \u03b1 mutations upregulate the unfolded protein response and are killed by BHPI","volume":"6","author":"Mao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0038","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2174\/1568026615666150413154841","article-title":"Structural and functional diversity of estrogen receptor ligands","volume":"15","author":"Farooq","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0039","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41598-017-17364-4","article-title":"A computational assay of estrogen receptor \u03b1 antagonists reveals the key common structural traits of drugs effectively fighting refractory breast cancers","volume":"8","author":"Pavlin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0041","doi-asserted-by":"crossref","first-page":"21737","DOI":"10.1073\/pnas.1007863107","article-title":"Estrogen expands breast cancer stem-like cells through paracrine FGF\/Tbx3 signaling","volume":"107","author":"Fillmore","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0042","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/bcr3396","article-title":"Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling","volume":"15","author":"Harrison","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<165::AID-PATH155>3.0.CO;2-Y","article-title":"Detection of oestrogen receptors in noninvasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique","volume":"186","author":"Kaufmann","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0044","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5858\/2005-129-194-EREIPU","article-title":"Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma","volume":"129","author":"Croft","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2009.01.033","article-title":"Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression","volume":"29","author":"Tuygun","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0046","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3349\/ymj.2014.55.5.1214","article-title":"Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer","volume":"55","author":"Nam","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2015.04.001","article-title":"The Estrogen Pathway: Estrogen Receptor-alpha, Progesterone Receptor, and Estrogen Receptor-beta Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens","author":"Tan","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0048","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000324262","article-title":"Expression of ER\u03b2 and its co-regulators p300 and NCoR in human transitional cell bladder cancer","volume":"87","author":"Kontos","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0049","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/or.2013.2416","article-title":"Estrogen receptor-beta expression and pharmacological targeting in bladder cancer","volume":"30","author":"Kauffman","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00345-011-0819-4","article-title":"Estrogen receptor \u03b2 (ER\u03b2) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch","volume":"30","author":"Han","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0051","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1038\/ncomms15840","article-title":"Insufficient antibody validation challenges oestrogen receptor beta research","volume":"8","author":"Andersson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0052","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/path.1077","article-title":"Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue","volume":"197","author":"Skliris","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0053","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1054\/bjoc.2001.1721","article-title":"Immunohistochemical detection of ER\u03b2 in breast cancer: toward more detailed receptor profiling?","volume":"84","author":"Skliris","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0054","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1158\/1078-0432.CCR-07-4528","article-title":"Nuclear and Cytoplasmic Expression of ER\u03b21, ER\u03b22, and ER\u03b25 Identifies Distinct Prognostic Outcome for Breast Cancer Patients","volume":"14","author":"Shaaban","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12672-012-0123-9","article-title":"Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation","volume":"4","author":"Hoffman","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0056","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/erc.1.01255","article-title":"Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation","volume":"15","author":"Teng","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/251780","article-title":"Roles of ER\u03b2 and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen","volume":"2015","author":"Huang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0059","first-page":"877","article-title":"Ligand-independent activation of the estrogen receptors \u03b1 and \u03b2 by mutations of a conserved tyrosine can be abolished by antiestrogens","volume":"58","author":"Tremblay","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0060","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American society of clinical oncology\/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0061","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1464-410x.2000.00724.x","article-title":"Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status","volume":"86","author":"Blakeman","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0062","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.juro.2008.10.104","article-title":"Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract","volume":"181","author":"Tincello","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0063","doi-asserted-by":"crossref","first-page":"15677","DOI":"10.1073\/pnas.95.26.15677","article-title":"Generation and reproductive phenotypes of mice lacking estrogen receptor","volume":"95","author":"Krege","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0064","doi-asserted-by":"crossref","first-page":"9806","DOI":"10.1073\/pnas.0703410104","article-title":"Estrogen receptor \u03b2-deficient female mice develop a bladder phenotype resembling human interstitial cystitis","volume":"104","author":"Imamov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/path.5230","article-title":"Molecular profiling in muscle invasive bladder cancer: more than the sum of its parts","author":"Sj\u00f6dahl","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0066","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A Consensus Molecular Classification of Muscle-invasive Bladder Cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0067","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.trecan.2015.08.011","article-title":"Why does infection with some helminths cause cancer?","volume":"1","author":"Brindley","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.urolonc.2020.04.022_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006393","article-title":"Helminth infection\u2013induced malignancy","volume":"13","author":"Brindley","year":"2017","journal-title":"PLOS Pathog"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920301587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:18:29Z","timestamp":1761041909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920301587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1078143920301587"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.022","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}